Compare LYB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYB | DGX |
|---|---|---|
| Founded | 1955 | 1967 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 23.1B |
| IPO Year | 2010 | 1996 |
| Metric | LYB | DGX |
|---|---|---|
| Price | $74.10 | $198.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $68.00 | ★ $208.62 |
| AVG Volume (30 Days) | ★ 7.8M | 621.3K |
| Earning Date | 05-01-2026 | 04-21-2026 |
| Dividend Yield | ★ 3.44% | 1.75% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | N/A | ★ 8.75 |
| Revenue | ★ $30,153,000,000.00 | $11,035,000,000.00 |
| Revenue This Year | $1.93 | $7.53 |
| Revenue Next Year | $0.13 | $3.77 |
| P/E Ratio | ★ N/A | $22.47 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $41.58 | $159.83 |
| 52 Week High | $83.94 | $213.50 |
| Indicator | LYB | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 51.11 |
| Support Level | $44.50 | $194.09 |
| Resistance Level | $83.94 | $203.96 |
| Average True Range (ATR) | 3.73 | 4.22 |
| MACD | -0.70 | 0.10 |
| Stochastic Oscillator | 36.23 | 58.05 |
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.